📋 Tender Overview
Amgen Boston Scientific Duke University FDA G1 Therapeutics Gilead Sciences Labcorp Medicenna Merck Moderna Parexel and more to discuss delivering the right therapy to the right patient at the right timeFormer FDA Commissioner Scott Gottlieb MD to return to the NEXT stage joining other top life science keynote speakersMedidata a Dassault Systmes company will convene experts in drug and device development clinical operations data management biostatistics and digital medicine industries to help solve the impossible at NEXT Global from October 5-7 2021. The industrys largest meeting of its kind includes renowned keynote speakers live and interactive roundtable discussions breakout sessions lightning talks customer success stories product demonstrations networking and wellness activities.The full program agenda can be found here. Sessions includeAbbVie Emerson Clinical Research Institute and Memorial Sloan Kettering Cancer Center Patient and Community Engagement Initiatives that Guarantee Diversity in Clinical TrialsAlkermes Chimerix and dMed-Clinipace Lessons Learned From The PandemicBoston Scientific Rapidly Changing Course with Remote MonitoringCSL Limited How Improving the Donor Experience Ultimately Helps PatientsDaiichi Sankyo and AbbVie Following The Journey Defining the Story Around Diversity in Clinical TrialsICON Medical Imaging Data Privacy and AI Oh My How to Integrate your Systems for SuccessIQVIA and Sanofi Transforming Clinical Data Capture and Management and Achieving Clinical Operations Excellence with CTMS and RBQMLabcorp Amgen and G1 Therapeutics Success Stories Highlighting Reimagined Clinical Trials with Patient-Centric Technologies AI-Powered Insights and Modern Data ManagementMedicenna Accelerating Insights and Breakthroughs in the Worlds Most Challenging Diseases with Synthetic Control ArmsModerna Pioneering a New Generation of Medicine The Digitized Delivery of a Vaccine in Record SpeedScott Gottlieb former Commissioner of the FDA Impacts of the Changing Industry and Regulatory LandscapeLisa Sanders of Yale The New York Times Magazine and Netflix Solving Medical Mysteries Through Crowdsourcing and Connectivity We had hoped to host an in-person event this year but this virtual format gives us the opportunity to pull together an even more robust line-up of experts and innovators including some of our incredible industry partners said Glen de Vries co-founder of Medidata and vice chair of Dassault Systmes Life Sciences Healthcare. Were pleased to provide the opportunity to bring so many dedicated inspired people together and share what weve all learned over the past year to move forward together for the sake of improving healthcare outcomes for all.With a focus on information exchange and discussing ways to solve the impossible through advanced technology and industry collaboration the three-day all virtual event will feature presentations from new Medidata co-CEOs Rama Kondru and Sastry Chilukuri as well as new Patient Cloud CEO Anthony Costello bringing together experts to discuss topics critical to pharmaceutical and biotechnology companies medical device and diagnostics companies and contract research organizations CROs.Were looking forward to diving deep into what we need to do to meet the needs of patients and the future of drug development how industry response needs to move from being pandemic-based to season-based and what needs to be done differently to form a more coordinated and integrated drug development and approval process for all involved added de Vries.NEXT Global attendance is free for customers partners and qualified members of the life sciences community. Medidata thanks NEXT Global sponsors Labcorp Syneos Health eClinical Solutions Capgemini Accenture ICON plc CTI Everest Clinical Research Parexel Advanced Clinical Clinipace Premier Research and Advanced Research Associates.Medidata is a wholly owned subsidiary of Dassault Systmes which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform from research to commercialization.